rs781610241
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM1PM2BP4
The NM_000303.3(PMM2):c.426T>G(p.Ile142Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000306 in 1,569,972 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000303.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PMM2 | NM_000303.3 | c.426T>G | p.Ile142Met | missense_variant | Exon 5 of 8 | ENST00000268261.9 | NP_000294.1 | |
PMM2 | XM_047434215.1 | c.177T>G | p.Ile59Met | missense_variant | Exon 3 of 6 | XP_047290171.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152220Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000209 AC: 4AN: 191302Hom.: 0 AF XY: 0.00000980 AC XY: 1AN XY: 102086
GnomAD4 exome AF: 0.0000296 AC: 42AN: 1417752Hom.: 0 Cov.: 30 AF XY: 0.0000313 AC XY: 22AN XY: 701924
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152220Hom.: 0 Cov.: 34 AF XY: 0.0000403 AC XY: 3AN XY: 74366
ClinVar
Submissions by phenotype
PMM2-congenital disorder of glycosylation Uncertain:3
- -
- -
This sequence change replaces isoleucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 142 of the PMM2 protein (p.Ile142Met). This variant is present in population databases (rs781610241, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with PMM2-related conditions. ClinVar contains an entry for this variant (Variation ID: 495798). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
Variant Summary: This PMM2 variant affects a non-conserved nucleotide, resulting in an amino acid change from Ile to Met. 3/4 in-silico tools predict this variant to be benign (SNPs&GO not captured due to low reliability index). Functional studies on this variant have not been carried out. This variant was found in 2/31948 control chromosomes at a frequency of 0.0000626, which does not exceed the maximal allele frequency of a pathogenic PMM2 variant (0.0055902). This variant has been reported in one patient with intellectual disability without a second pathogenic allele (Redin_2014) and authors predict the variant to be possibly benign. Because of limited clinical information and the lack of functional studies, the variant was classified as a variant of uncertain significance (VUS) until additional information becomes available. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at